Diabetes, Obesity & Metabolism
Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study
Computational studyInterventions
Papers by Long Ren
1 result